PE
PRTA icon

Point72 Europe’s Prothena Corp PRTA Stock Holding History

Point72 Europe’s Portfolio PRTA Stock Details PRTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$5.18K Buy
+531
New +$4.08K ﹤0.01% 597

Other funds holding PRTA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Point72 Europe's PRTA Position: Q3 2025 in Review

Point72 Europe opened a new position in Prothena Corp (PRTA) in Q3 2025: 531 shares worth $5.18K. The stake represents ﹤0.01% of the portfolio and ranks #597 among its holdings.

187 funds tracked by Wall St. Rank hold PRTA as of Q3 2025.

  • Point72 Europe held 531 shares of Prothena Corp worth $5.18K as of Q3 2025.
  • Prothena Corp was a new Point72 Europe position in Q3 2025.
  • Prothena Corp made up ﹤0.01% of Point72 Europe's portfolio in Q3 2025, its #597 holding.
  • 187 funds tracked by Wall St. Rank held Prothena Corp as of Q3 2025.

Based on Point72 Europe's 13F filing for Q3 2025, filed 14 Nov 2025.